Sprinzl, MF; Schimanski, CC; Möhler, M et al.
Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report.BMC Cancer. Bd. 6. 2006 S. 190
Wörns, A; Victor, A; Galle, PR et al.
Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels - a study in twins.Genes Immun. Bd. 7. 2006 S. 600-605
Teufel, A; Wörns, MA; Weinmann, A et al.
Genetic association of autoimmune hepatitis and human leucocyte antigen in German patients.World J Gastroenterol. Bd. 12. H. 34. 2006 S. 5513-6
Schwarting, A
Genetic predisposition-is lupus nephritis a question of copy numbers?Nephrol Dial Transplant. Bd. 21. H. 9. 2006 S. 2378-9
Böcher, WO; Nienhaus, A
Hepatitis A: Relevantes Infektionsrisiko durch akzidentelle Nadelstichverletzung?Ergo Med. Bd. 4. 2006 S. 14-19
Sprinzl, MF; Otto, G; Galle, PR et al.
Hepatitis C virus re-infection: new perspectives.Clin Transplant. Bd. 20 Suppl 17. 2006 S. 117-123
Becker, CH; Fantini, MC; Neurath, MF
High resolution colonoscopy in live mice.Nat Protoc. Bd. 1. 2006 S. 2900-2904
Schuchmann, M; Schulze-Bergkamen, H; Fleischer, B et al.
Histone deacetylase inhibition by valproic acid downregulates c-FLIP and sensitizes hepatoma cells towards CD95- and TRAIL-receptor mediated apoptosis and chemotherapy.Oncol Rep. Bd. 15. H. 1. 2006 S. 227-230
Götz, M; Kiesslich, R; Galle, PR
Humanisierter Anti-TNF-Antikörper bei M. Crohn. Kommentar zu S. B. Hanauer et al., Human Anti-Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial.Gastro Update. Bd. 3. 2006 S. 10-12
Florin, L; Becker, KA; Lambert, C et al.
Identification of a dynein interacting domain in the papillomavirus minor capsid protein l2.J Virol. Bd. 80. H. 13. 2006 S. 6691-6